Skip to results
Modify your search
NARROW
1-9 of 9
Authors: Yun Qiu
Sort by
Journal Article
Developing a Machine-Learning Prediction Model for Infliximab Response in Crohn’s Disease: Integrating Clinical Characteristics and Longitudinal Laboratory Trends
Get access
Yun Qiu and others
Inflammatory Bowel Diseases, izae176, https://doi.org/10.1093/ibd/izae176
Published: 10 August 2024
Journal Article
Longitudinal Bowel Behavior Assessed by Bowel Ultrasound to Predict Early Response to Anti-TNF Therapy in Patients With Crohn’s Disease: A Pilot Study
Yu-Jun Chen and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_2, June 2022, Pages S67–S75, https://doi.org/10.1093/ibd/izab353
Published: 04 January 2022
Journal Article
EDITOR'S CHOICE
Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn’s Disease
Xiaojun Zhuang and others
Inflammatory Bowel Diseases, Volume 26, Issue 11, November 2020, Pages 1636–1647, https://doi.org/10.1093/ibd/izaa253
Published: 07 October 2020
Journal Article
Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease
Get access
Xiaojun Zhuang and others
Inflammatory Bowel Diseases, Volume 25, Issue 11, November 2019, Pages 1751–1763, https://doi.org/10.1093/ibd/izz188
Published: 09 September 2019
Journal Article
Association of Infliximab Levels With Mucosal Healing Is Time-Dependent in Crohn’s Disease: Higher Drug Exposure Is Required Postinduction Than During Maintenance Treatment
Get access
Ting Feng and others
Inflammatory Bowel Diseases, Volume 25, Issue 11, November 2019, Pages 1813–1821, https://doi.org/10.1093/ibd/izz061
Published: 01 April 2019
Journal Article
Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway
Get access
Li Li and others
Inflammatory Bowel Diseases, Volume 24, Issue 10, October 2018, Pages 2211–2223, https://doi.org/10.1093/ibd/izy187
Published: 16 May 2018
Journal Article
Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease
Get access
Ting Feng and others
Inflammatory Bowel Diseases, Volume 23, Issue 10, 1 October 2017, Pages 1817–1824, https://doi.org/10.1097/MIB.0000000000001172
Published: 20 June 2017
Journal Article
Reply to Can Fecal Calprotection Identify Postoperative Recurrence of Crohn's Disease?
Get access
Yun Qiu
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Page E7, https://doi.org/10.1097/MIB.0000000000000416
Published: 04 April 2015
Journal Article
Fecal Calprotectin for Evaluating Postoperative Recurrence of Crohn's Disease: A Meta-analysis of Prospective Studies
Get access
Yun Qiu and others
Inflammatory Bowel Diseases, Volume 21, Issue 2, 1 February 2015, Pages 315–322, https://doi.org/10.1097/MIB.0000000000000262
Published: 07 January 2015
Advertisement
Advertisement